These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10652771)

  • 21. Diagnostic Performance of Clock Drawing Test by CLOX in an Asian Chinese population.
    Yap PL; Ng TP; Niti M; Yeo D; Henderson L
    Dement Geriatr Cogn Disord; 2007; 24(3):193-200. PubMed ID: 17690551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective screening for Alzheimer's disease in everyday practice.
    Lee SS
    JAAPA; 2001 Jul; 14(7):39-48. PubMed ID: 11517820
    [No Abstract]   [Full Text] [Related]  

  • 23. Visual exploration behaviour during clock reading in Alzheimer's disease.
    Mosimann UP; Felblinger J; Ballinari P; Hess CW; Müri RM
    Brain; 2004 Feb; 127(Pt 2):431-8. PubMed ID: 14691059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Early diagnosis of Alzheimer disease].
    Touchon J; Ritchie K; Gely-Nargeot MC
    Ann Med Interne (Paris); 1998 Jun; 149(4):193-201. PubMed ID: 11490546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alzheimer's disease. The importance of early diagnosis].
    Mahleux F
    Rev Infirm; 2004 Jan; (97):18-20. PubMed ID: 15027137
    [No Abstract]   [Full Text] [Related]  

  • 26. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Should we revise the Alzheimer's disease diagnostic criteria?].
    Derouesné C
    Psychol Neuropsychiatr Vieil; 2008 Mar; 6(1):81-2. PubMed ID: 18441609
    [No Abstract]   [Full Text] [Related]  

  • 28. Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases.
    Lambon Ralph MA; Patterson K; Graham N; Dawson K; Hodges JR
    Brain; 2003 Nov; 126(Pt 11):2350-62. PubMed ID: 12876147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simple scoring system for clock drawing in patients with Alzheimer's disease.
    Shua-Haim J; Koppuzha G; Gross J
    J Am Geriatr Soc; 1996 Mar; 44(3):335. PubMed ID: 8600212
    [No Abstract]   [Full Text] [Related]  

  • 30. [Before dementia--early features in Alzheimer's disease].
    Pulliainen V; Kuikka P
    Duodecim; 1998; 114(1):21-30. PubMed ID: 10895463
    [No Abstract]   [Full Text] [Related]  

  • 31. Re: De Jager, CA, et al. Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease.
    Royall DR
    Psychol Med; 2004 May; 34(4):761-2. PubMed ID: 15099434
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of prodromal Alzheimer's disease.
    Mortimer JA; Petersen RC
    Ann Neurol; 2008 Nov; 64(5):479-80. PubMed ID: 19067352
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease.
    Gillen TE; Gregg KM; Yuan H; Kurth MC; Krishnan KR
    Psychopharmacol Bull; 2001; 35(2):83-96. PubMed ID: 12397889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mild cognitive impairment, healthy aging and Alzheimer's disease.
    Wu CK
    Med Health R I; 2008 May; 91(5):132-3. PubMed ID: 18549037
    [No Abstract]   [Full Text] [Related]  

  • 35. Implicit memory and Alzheimer's disease neuropathology.
    Fleischman DA; Wilson RS; Gabrieli JD; Schneider JA; Bienias JL; Bennett DA
    Brain; 2005 Sep; 128(Pt 9):2006-15. PubMed ID: 15975947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance analysis of amygdalar volume in Alzheimer's disease.
    Horínek D; Varjassyová A; Hort J
    Curr Opin Psychiatry; 2007 May; 20(3):273-7. PubMed ID: 17415082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clock drawing and Alzheimer's disease.
    Miller DK
    J Am Geriatr Soc; 1990 Mar; 38(3):388-9. PubMed ID: 2313019
    [No Abstract]   [Full Text] [Related]  

  • 38. Uncertain progress on the fuzzy boundaries of Alzheimer's disease: reading between the guidelines.
    Whitehouse PJ; George DR
    J Alzheimers Dis; 2011; 26(1):1-5. PubMed ID: 21743133
    [No Abstract]   [Full Text] [Related]  

  • 39. [Predictive signs of Alzheimer's disease].
    Amieva H
    Rev Med Interne; 2011 Jun; 32 Suppl 1():S12-3. PubMed ID: 21477900
    [No Abstract]   [Full Text] [Related]  

  • 40. The CAMCOG for patients with Alzheimer's disease with low levels of education.
    Lourenço RA; Paradela EM
    Int Psychogeriatr; 2012 Aug; 24(8):1359-60; author reply 1360-1. PubMed ID: 22436203
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.